South Africa

Biotech collaboration paves way for first African-owned COVID-19 vaccine
Africans rising article comment count is: 0

Africans rising Biotech collaboration paves way for first African-owned COVID-19 vaccine

A collaboration between two leading biotech companies, the South Africa-based Afrigen and the Belgium-based Univercells will work together to develop a novel regional mRNA vaccine. The companies intend to confront the lack of local cost-effective production and the need for cold or super-cold chains that have hampered vaccination thus far.